MX2023014123A - Metodo para producir derivado de benzoxazol que tiene anillo biciclico de piperazina o sal de este y metodo para producir materia prima de este. - Google Patents
Metodo para producir derivado de benzoxazol que tiene anillo biciclico de piperazina o sal de este y metodo para producir materia prima de este.Info
- Publication number
- MX2023014123A MX2023014123A MX2023014123A MX2023014123A MX2023014123A MX 2023014123 A MX2023014123 A MX 2023014123A MX 2023014123 A MX2023014123 A MX 2023014123A MX 2023014123 A MX2023014123 A MX 2023014123A MX 2023014123 A MX2023014123 A MX 2023014123A
- Authority
- MX
- Mexico
- Prior art keywords
- producing
- salt
- sup
- formula
- compound represented
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4995—Pyrazines or piperazines forming part of bridged ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Health & Medical Sciences (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021108230 | 2021-06-30 | ||
| PCT/JP2022/026168 WO2023277120A1 (ja) | 2021-06-30 | 2022-06-30 | 二環性ピペラジン環を有するベンゾオキサゾール誘導体又はその塩の製造方法、並びに、その原料の製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023014123A true MX2023014123A (es) | 2023-12-12 |
Family
ID=84691891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023014123A MX2023014123A (es) | 2021-06-30 | 2022-06-30 | Metodo para producir derivado de benzoxazol que tiene anillo biciclico de piperazina o sal de este y metodo para producir materia prima de este. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240309010A1 (https=) |
| EP (1) | EP4365174A4 (https=) |
| JP (2) | JP7476431B2 (https=) |
| KR (1) | KR20240027603A (https=) |
| CN (2) | CN121873082A (https=) |
| AR (1) | AR126290A1 (https=) |
| AU (1) | AU2022300611A1 (https=) |
| BR (1) | BR112023025934A2 (https=) |
| CA (1) | CA3223354A1 (https=) |
| IL (1) | IL309736A (https=) |
| MX (1) | MX2023014123A (https=) |
| WO (1) | WO2023277120A1 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9890142B2 (en) * | 2013-07-10 | 2018-02-13 | Meiji Seika Pharma Co., Ltd. | PDE4 inhibitor |
| MX389276B (es) * | 2016-12-26 | 2025-03-20 | Meiji Seika Pharma Co Ltd | Compuesto novedoso y sal de este aceptable desde el punto de vista farmacologico. |
| KR102931303B1 (ko) * | 2018-06-27 | 2026-02-25 | 메이지 세이카 파루마 가부시키가이샤 | 염증성 질환, 자가면역 질환, 섬유화 질환 및 암 질환의 치료제 |
| JP2021155336A (ja) * | 2018-06-27 | 2021-10-07 | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | 新規ｐｄｅ４阻害剤 |
-
2022
- 2022-06-30 MX MX2023014123A patent/MX2023014123A/es unknown
- 2022-06-30 JP JP2023532045A patent/JP7476431B2/ja active Active
- 2022-06-30 CN CN202610020318.9A patent/CN121873082A/zh active Pending
- 2022-06-30 IL IL309736A patent/IL309736A/en unknown
- 2022-06-30 CA CA3223354A patent/CA3223354A1/en active Pending
- 2022-06-30 KR KR1020237043708A patent/KR20240027603A/ko active Pending
- 2022-06-30 WO PCT/JP2022/026168 patent/WO2023277120A1/ja not_active Ceased
- 2022-06-30 EP EP22833266.4A patent/EP4365174A4/en active Pending
- 2022-06-30 BR BR112023025934A patent/BR112023025934A2/pt unknown
- 2022-06-30 AU AU2022300611A patent/AU2022300611A1/en active Pending
- 2022-06-30 AR ARP220101722A patent/AR126290A1/es unknown
- 2022-06-30 US US18/575,158 patent/US20240309010A1/en active Pending
- 2022-06-30 CN CN202280035356.1A patent/CN117295744A/zh active Pending
-
2024
- 2024-04-17 JP JP2024067062A patent/JP7839217B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP7839217B2 (ja) | 2026-04-01 |
| CN117295744A (zh) | 2023-12-26 |
| EP4365174A4 (en) | 2025-07-02 |
| US20240309010A1 (en) | 2024-09-19 |
| KR20240027603A (ko) | 2024-03-04 |
| BR112023025934A2 (pt) | 2024-02-27 |
| JP7476431B2 (ja) | 2024-04-30 |
| EP4365174A1 (en) | 2024-05-08 |
| AU2022300611A1 (en) | 2024-01-25 |
| WO2023277120A1 (ja) | 2023-01-05 |
| CN121873082A (zh) | 2026-04-17 |
| AR126290A1 (es) | 2023-10-04 |
| TW202311242A (zh) | 2023-03-16 |
| JP2024096941A (ja) | 2024-07-17 |
| JPWO2023277120A1 (https=) | 2023-01-05 |
| IL309736A (en) | 2024-02-01 |
| CA3223354A1 (en) | 2023-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY146646A (en) | 2,3-dihydro-6-nitroimidazo [2,1-b] oxazole compounds for the treatment of tuberculosis | |
| EP1681285A4 (en) | DIAMINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF, AND PLANT DISEASE AGENT CONTAINING SAID DERIVATIVES AS AN ACTIVE INGREDIENT | |
| CY1114836T1 (el) | Παραγωγο δικυκλικου γ-αμινοξεος | |
| CY1113099T1 (el) | Παραγωγα (θειο)καρβαμοϋλ-κυκλοεξανιου ως ανταγωνιστες των υποδοχεων d3/d2 | |
| JO2864B1 (en) | Circular amine compounds | |
| PH12019501391A1 (en) | Novel compound and pharmacologically acceptable salt thereof | |
| TW200738667A (en) | Preparation method for dioxan-2-ylalkylcarbamate derivatives and intermediate thereof | |
| TW200505834A (en) | Sulfamide derivative and the pharmaceutical composition thereof | |
| JO2413B1 (en) | Benzoxazine derivatives and their use | |
| PH12015501098A1 (en) | Antituberculous composition comprising oxazole compounds | |
| NZ569867A (en) | Novel 11 Beta-hydroxyandrosta-4-ene-3-ones | |
| PH12017501655B1 (en) | Morphinan derivative | |
| WO2008136444A1 (ja) | 縮合複素環誘導体 | |
| DE3675226D1 (de) | Triazinderivate, verfahren zur herstellung der derivate und die derivate als wirksamen bestandteil enthaltende herbizide. | |
| MX2023004102A (es) | Derivado de gamma-carbolina fusionado sustituido con heterociclo, metodo de preparacion del mismo, intermediarios del mismo y uso del mismo. | |
| MX2023014123A (es) | Metodo para producir derivado de benzoxazol que tiene anillo biciclico de piperazina o sal de este y metodo para producir materia prima de este. | |
| MX2023010000A (es) | Metodo para el control de artropodos da?inos o nematodos da?inos mediante el uso de zoantaminas. | |
| YU43902A (sh) | Novi razgranati supstituisani amino derivati od 3-amino-1- -fenil-1h(1,2,4) triazola, postupak za njihovo dobijanje i farmaceutski preparati koji ih sadrže | |
| MXPA04005837A (es) | Nuevos derivados de benzotiazina y benzotiadiazina, metodo para su preparacion y composiciones farmaceuticas que los contienen. | |
| NO20052023L (no) | Kalsium aktivert K kanal apner med hoy konduktans | |
| IL158641A0 (en) | Process for preparing a thiazole ppar-ligand and polymorphs thereof | |
| ES2116513T3 (es) | Procedimiento para la preparacion de derivados de eritro-3-amino-1,2-epoxidos opticamente activos. | |
| ATE424390T1 (de) | Verfahren zur herstellung von delmopinol und derivaten davon | |
| MXPA01009615A (es) | Procedimiento para la preparacion de acido [s -(r*s*)] -°-[[[1[1- oxo-3 -(4-piperidinil) propil]3 -piperidini] carbonil] amino] -3-piridinil] carbonil] amino] -3-piridinpropanoico, y derivados del mismo. | |
| MY189525A (en) | Methods for producing nitroso compound and quinoxaline compound |